Skip to main content
Premium Trial:

Request an Annual Quote

Febit Inks Biosecurity Development Deal with In-Q-Tel

NEW YORK (GenomeWeb News) – Febit today said that it has signed a strategic investment and technology development agreement with In-Q-Tel to further develop Febit’s Geniom technology for biosecurity applications.
 
The firms expect to improve the multiplex Geniom system for detection and classification of known and unknown pathogens.
 
“Febit’s partnership with In-Q-Tel enables us to focus on the field of pathogen detection, and further enhance an application-oriented device with well-defined requirements, similar to what we have developed in the field of microRNA analysis with the Geniom RT Analyzer,” Febit CEO Cord Staehler said in a statement.
 
In-Q-Tel is a non-profit investment firm created by the Central Intelligence Agency in 1999 with the goal of identifying and developing technology to support the mission of the US intelligence community.
 
Financial and other terms of the alliance were not disclosed.
 

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.